glp 1 gip dual agonist GIPR/GLP-1R therapies for diabetes and weight loss– Chemistry, Physiology and Clinical application Dual GLP-1 / GIP Receptor
Description
doi: 10.1210/endo.133.1.8391428
Management of Hyperglycemia in Type 2 Diabetes, A consensus report by the american diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
While randomized prevention trials are still needed, the consistency and biological coherence of current data support cautious optimism
Skibickas lab has found that women, on average, lose more weight than men on equivalent doses, possibly due to interactions between GLP-1 signaling and estrogen
[DOI] [PubMed] [Google Scholar] 43.Lpez-Mora DA, et al
Garvey, N
